RIL
AVDL

Rothschild Investment LLC’s Avadel Pharmaceuticals AVDL Stock Holding History

Rothschild Investment LLC’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-210
Closed -$4.53K – 3611
2025
Q4 		$4.53K Hold
210
– – ﹤0.01% 1948
2025
Q3 		$3.21K Sell
210
-20
-9% -$260 ﹤0.01% 1946
2025
Q2 		$2.04K Buy
230
+70
+44% +$615 ﹤0.01% 2068
2025
Q1 		$1.25K Buy
160
+145
+967% +$1.21K ﹤0.01% 2209
2024
Q4 		$158 Sell
15
-70
-82% -$850 ﹤0.01% 2832
2024
Q3 		$1.11K Buy
85
+75
+750% +$1.14K ﹤0.01% 2095
2024
Q2 		$141 Buy
+10
New +$163 ﹤0.01% 2600

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Rothschild Investment LLC's AVDL Position: Q1 2026 in Review

Rothschild Investment LLC sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 210 shares — an estimated $4.53K sold.

Rothschild Investment LLC first reported a position in AVDL in Q2 2024 and held it in 7 quarters. The position peaked at $4.53K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Rothschild Investment LLC reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Rothschild Investment LLC sold 210 Avadel Pharmaceuticals shares in Q1 2026, an estimated $4.53K.
  • Rothschild Investment LLC first reported a position in Avadel Pharmaceuticals in Q2 2024 and held it in 7 quarters.
  • Rothschild Investment LLC's Avadel Pharmaceuticals position peaked at $4.53K in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.